The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Camptothecin: current perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Saltz, L. B., Cox, J. V., Blanke, C., Rosen, L. S., Fehrenbacher, L., Moore, M. J., Maroun, J. A., Ackland, S. P., Locker, P. K., Pirotta, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431302 · Cited by 3,005
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Self-citationWall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNA
Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J., & Hol, W. G. J. (1998) · Science · doi:10.1126/science.279.5356.1504 · Cited by 889
The mechanism of topoisomerase I poisoning by a camptothecin analog
Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B., & Stewart, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242259599 · Cited by 818
DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts
Giovanella, B. C., Stehlin, J. S., Wall, M. E., Wani, M. C., Nicholas, A. W., Liu, L. F., Silber, R., & Potmesil, M. (1989) · Science · doi:10.1126/science.2555920 · Cited by 650
The Current Status of Camptothecin Analogues as Antitumor Agents
Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., & Kaufmann, S. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.271 · Cited by 618
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
Pommier, Y., Pourquier, P., Fan, Y., & Strumberg, D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00129-8 · Cited by 551
Hertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a018 · Cited by 551
Self-citationKingsbury, W. D., Boehm, J. C., Jakas, D. R., Holden, K. G., Hecht, S. M., Gallagher, G., Caranfa, M. J., McCabe, F. L., Faucette, L. F., Johnson, R. K., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a017 · Cited by 518
Self-citationMechanism of Action of Camptothecin
Liu, L. F., Duann, P., Lin, C., D'Arpa, P., & Wu, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb26375.x · Cited by 508
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
Nitiss, J., & Wang, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7501 · Cited by 499
García‐Carbonero, R., & Supko, J. G. (2002) · PubMed · Cited by 498
Mechanism of Action of Camptothecin
LIU, L. F., DESAI, S. D., LI, T., MAO, Y., SUN, M., & SIM, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07020.x · Cited by 476
A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some Analogues
Fassberg, J., & Stella, V. J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810718 · Cited by 464
Hertzberg, R. P., Caranfa, M. J., Holden, K. G., Jakas, D. R., Gallagher, G., Mattern, M. R., Mong, S. M., Bartus, J. O., Johnson, R. K., & Kingsbury, W. D. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00123a038 · Cited by 413
DNA topoisomerase I is involved in both repression and activation of transcription
Merino, A., Madden, K. R., Lane, W. S., Champoux, J. J., & Reinberg, D. (1993) · Nature · doi:10.1038/365227a0 · Cited by 385
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang, Y. H., Liu, L. F., Wall, M. E., Wani, M. C., Nicholas, A. W., Manikumar, G., Kirschenbaum, S., Silber, R., & Potmĕsil, M. (1989) · PubMed · Cited by 339
Eukaryotic DNA Polymerases: Proposal for a Revised Nomenclature
Burgers, P. M. J., Koonin, E. V., Bruford, E., Blanco, L., Burtis, K. C., Christman, M. F., Copeland, W. C., Friedberg, E. C., Hanaoka, F., Hinkle, D. C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100056200 · Cited by 337
Irinotecan in the Treatment of Colorectal Cancer: Clinical Overview
Vanhoefer, U., Harstrick, A., Achterrath, W., Cao, S., Seeber, S., & Rustum, Y. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1501 · Cited by 326
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I
Rossi, F., Labourier, E., Forné, T., Divita, G., Derancourt, J., Riou, J. F., Antoine, E., Cathala, G., Brunel, C., & Tazi, J. (1996) · Nature · doi:10.1038/381080a0 · Cited by 326
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
Eng, W. K., Faucette, L., Johnson, R. K., & Sternglanz, R. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10121-1 · Cited by 325
Reduction of natural enones in the presence of cerium trichloride
Luche, J.-L., Rodriguez-Hahn, L., & Crabbé, P. (1978) · J. Chem. Soc., Chem. Commun. · doi:10.1039/c39780000601 · Cited by 308
Three-dimensional structure of the 67K N-terminal fragment of E. coli DNA topoisomerase I
Lima, C. D., Wang, J. C., & Mondragón, A. (1994) · Nature · doi:10.1038/367138a0 · Cited by 308
Differential Interactions of Camptothecin Lactone and Carboxylate Forms with Human Blood Components
Mi, Z., & Burke, T. G. (1994) · Biochemistry · doi:10.1021/bi00200a013 · Cited by 300
Camptothecins: A Review of Their Chemotherapeutic Potential
Ulukan, H., & Swaan, P. W. (2002) · Drugs · doi:10.2165/00003495-200262140-00004 · Cited by 299
Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse.
KANEDA, N., Nagata, H., Furuta, T., & YOKOKURA, T. (1990) · PubMed · Cited by 291
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
Andoh, T., Ishii, K., Suzuki, Y., Ikegami, Y., Kusunoki, Y., Takemoto, Y., & Okada, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5565 · Cited by 287
Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin
Desai, S. D., Liu, L. F., Vazquez-Abad, D., & D'Arpa, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24159 · Cited by 269
Bjornsti, M., Benedetti, P., Viglianti, G. A., & Wang, J. C. (1989) · PubMed · Cited by 264
Topoisomerase I inhibitors: topotecan and irenotecan
Creemers, G. J., Lund, B., & Verweij, J. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90011-6 · Cited by 252
Covey, J. M., Jaxel, C., Kohn, K. W., & Pommier, Y. (1989) · PubMed · Cited by 245
Husain, I., Mohler, J. L., Seigler, H. F., & Besterman, J. M. (1994) · PubMed · Cited by 244
Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogs
Wani, M. C., Ronman, P. E., Lindley, J. T., & Wall, M. E. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00179a016 · Cited by 234
Schimke, R. T., Sherwood, S. W., Hill, A. B., & Johnston, R. N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2157 · Cited by 232
Desai, S. D., Li, T., Rodriguez-Bauman, A., Rubin, E. H., & Liu, L. F. (2001) · PubMed · Cited by 219
Studies on the Antitumor Activity, Mechanism of Action, and Cell Cycle Effects of Camptothecin
(1971) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/46.4.789 · Cited by 215
Camptothecins: a review of their development and schedules of administration
O’Leary, J., & Muggia, F. M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00229-9 · Cited by 212
Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase Inhibitors
Pommier, Y., Pharm, D., Fesen, M. R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G., & Kohn, K. W. (1994) · Cancer Investigation · doi:10.3109/07357909409021413 · Cited by 207
Pol κ: A DNA Polymerase Required for Sister Chromatid Cohesion
Wang, Z., Castaño, I. B., De Las Peñas, A., Adams, C., & Christman, M. F. (2000) · Science · doi:10.1126/science.289.5480.774 · Cited by 186
Topoisomerase I inhibitors: selectivity and cellular resistance
Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J., & Laco, G. S. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0102 · Cited by 182
Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin
Fan, Y., Weinstein, J. N., Kohn, K. W., Shi, L. M., & Pommier, Y. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9605445 · Cited by 173
Kretzschmar, M., Meisterernst, M., & Roeder, R. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11508 · Cited by 168
Mitsui, I., Kumazawa, E., Hirota, Y., Aonuma, M., Sugimori, M., Ohsuki, S., Uoto, K., Ejima, A., Terasawa, H., & Sato, K. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb02468.x · Cited by 165
20-O-Acylcamptothecin Derivatives: Evidence for Lactone Stabilization
Zhao, H., Lee, C., Sai, P., Choe, Y. H., Boro, M., Pendri, A., Guan, S., & Greenwald, R. B. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo000221n · Cited by 162
Fan, Y., Shi, L. M., Kohn, K. W., Pommier, Y., & Weinstein, J. N. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0005151 · Cited by 162
Lipid bilayer partitioning and stability of camptothecin drugs
Burke, T. G., Mishra, A. K., Wani, M. C., & Wall, M. E. (1993) · Biochemistry · doi:10.1021/bi00071a010 · Cited by 156
New technique for uncoupling the cleavage and religation reactions of Eukaryotic Topoisomerase I.
Svejstrup, J. Q., Christiansen, K., Gromova, I., Andersen, A. H., & Westergaard, O. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90503-x · Cited by 155
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
Lavergne, O., Lesueur‐Ginot, L., Rodas, F. P., Kasprzyk, P. G., Pommier, J., Demarquay, D., Prevost, G. P., Ulíbarri, G., Rolland, A., Schiano, A., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980400l · Cited by 155
Fujimori, A., Harker, W. G., Kohlhagen, G., Hoki, Y., & Pommier, Y. G. (1995) · PubMed · Cited by 151
Luzzio, M. J., Besterman, J. M., Emerson, D. L., Evans, M. G., Lackey, K. E., Leitner, P. L., McIntyre, G. D., Morton, B. S., Myers, P. L., Peel, M. R., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00003a001 · Cited by 145
Yamashita, Y., Fujii, N., Murakata, C., Ashizawa, T., Okabe, M., & Nakano, H. (1992) · Biochemistry · doi:10.1021/bi00163a015 · Cited by 145
Tamura, H.-O., Kohchi, C., Yamada, R., Ikeda, T., Koiwai, O., Patterson, E., Keene, J. D., Okada, K., Kjeldsen, E., Nishikawa, K., et al. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.1.69 · Cited by 143
Redinbo, M. R., Champoux, J. J., & Hol, W. G. J. (2000) · Biochemistry · doi:10.1021/bi992690t · Cited by 142
Studies on camptothecin. I. Effects of nucleic acid and protein synthesis.
Horwitz, S. B., Chang, C.-K., & Grollman, A. P. (1971) · PubMed · Cited by 141
Mi, Z., & Burke, T. G. (1994) · Biochemistry · doi:10.1021/bi00208a002 · Cited by 140
Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogs
Wani, M. C., Nicholas, A. W., & Wall, M. E. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00161a035 · Cited by 138
CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties.
Tsuji, T., Kaneda, N., Kunio, K. A. D. O., Yokokura, T., YOSHIMOTO, T., & Tsuru, D. (1991) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.14.341 · Cited by 136
Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Meng, L., Zhi-yong, L., & Pommier, Y. G. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452546 · Cited by 132
Inhibition of topoisomerase I function by nitidine and fagaronine
Wang, L., Johnson, R. K., & Hecht, S. M. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00036a010 · Cited by 130
Self-citationIntra- and intermolecular strand transfer by HeLa DNA topoisomerase I.
Halligan, B. D., Davis, J. L., Edwards, K. A., & Liu, L. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34881-6 · Cited by 124
Conover, C. D., Greenwald, R. B., Pendri, A., Gilbert, C. W., & Shum, K. L. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050837 · Cited by 122
Castaño, I., Brzoska, P. M., Sadoff, B. U., Chen, H., & Christman, M. F. (1996) · Genes & Development · doi:10.1101/gad.10.20.2564 · Cited by 117
Curran, D. P., Ko, S., & Josien, H. B. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199526831 · Cited by 116
Wani, M. C., Nicholas, A. W., Manikumar, G., & Wall, M. E. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00393a016 · Cited by 114
Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin
Horwitz, M. S., & Horwitz, S. B. (1971) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(71)90476-1 · Cited by 108
Burke, T. G., Munshi, C. B., Mi, Z., & Jiang, Y. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840426 · Cited by 105
Hertzberg, R., Busby, R. W., Caranfa, M. J., Holden, K. G., Johnson, R. K., Hecht, S. M., & Kingsbury, W. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30656-7 · Cited by 99
Self-citationUrasaki, Y., Laco, G. S., Pourquier, P., Takebayashi, Y., Kohlhagen, G., Gioffre, C., Zhang, H., Chatterjee, D., Pantazis, P., & Pommier, Y. G. (2001) · PubMed · Cited by 99
Cao, Z., Harris, N., Kozielski, A. J., Vardeman, D., Stehlin, J. S., & Giovanella, B. C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9607562 · Cited by 99
Liposomal stabilization of camptothecin's lactone ring
Burke, T. G., Staubus, A. E., Mishra, A. K., & Malak, H. M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00047a069 · Cited by 97
Camptothecin effects on DNA synthesis in murine leukemia cells
Kessel, D. H., Bosmann, H. B., & Lohr, K. M. (1972) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(72)90429-7 · Cited by 88
DNA strand transfer reactions catalyzed by vaccinia topoisomerase I.
Shuman, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42488-x · Cited by 85
Christiansen, K., Dirac-Svejstrup, A. B., Andersen, A. H., & Westergaard, O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98404-8 · Cited by 84
Leu, Y.-L., Roffler, S. R., & Chern, J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990124q · Cited by 78
In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
Emerson, D. L., Besterman, J. M., Brown, H. R., Evans, M. G., Leitner, P., Luzzio, M. J., Shaffer, J. E., Sternbach, D. D., Uehling, D., & Vuong, A. (1995) · PubMed · Cited by 77
Castaño, I., Heath‐Pagliuso, S., Sadoff, B. U., Fitzhugh, D. J., & Christman, M. F. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.12.2404 · Cited by 77
Kohn, K. W., & Pommier, Y. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07021.x · Cited by 76
Mechanisms of Topoisomerase I Inhibition by Anticancer Drugs
Pommier, Y. G., Tanizawa, A., & Kohn, K. W. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61132-1 · Cited by 75
Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11
Sadzuka, Y., Hirotsu, S., & Hirota, S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00031-7 · Cited by 74
DNA Interactions of Two Clinical Camptothecin Drugs Stabilize Their Active Lactone Forms
Yang, D., Strode, J. T., Spielmann, H. P., Wang, A. H. ‐., & Burke, T. G. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973433j · Cited by 71
Cesare, M. D., Pratesi, G., Perego, P., Carenini, N., Tinelli, S., Merlini, L., Penco, S., Pisano, C., Bucci, F., Vesci, L., et al. (2001) · PubMed · Cited by 68
Mammalian topoisomerase I has base mismatch nicking activity.
Yeh, Y. C., Liu, H. F., Ellis, C. A., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40707-1 · Cited by 67
7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agents
Josien, H. B., Bom, D. C., Curran, D. P., Zheng, Y., & Chou, T. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)10181-0 · Cited by 65
Role of the 20-Hydroxyl Group in Camptothecin Binding by the Topoisomerase I−DNA Binary Complex
Wang, X., Zhou, X., & Hecht, S. M. (1999) · Biochemistry · doi:10.1021/bi982708k · Cited by 64
Self-citationRallabhandi, P., Hashimoto, K., Mo, Y. Y., Beck, W. T., MOITRA, P. K., & D’Arpa, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200388200 · Cited by 63
Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin
Hautefaye, P., Cimetiere, B., Pierré, A., Léonce, S., Hickman, J. A., Laine, W., Bailly, C., & Lavielle, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00534-1 · Cited by 61
Synthesis of an immunoconjugate of camptothecin
Walker, M. A., Dubowchik, G. M., Hofstead, S. J., Trail, P. A., & Firestone, R. A. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00707-7 · Cited by 53
Arimondo, P. B., Boutorine, A. S., Baldeyrou, B., Bailly, C., Kuwahara, M., Hecht, S. M., Sun, J., Garestier, T., & Hélène, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110181200 · Cited by 50
Self-citationMatteucci, M. D., Lin, K., Huang, T., Wagner, R., Sternbach, D. D., Mehrotra, M. M., & Besterman, J. M. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702475 · Cited by 45
van Hattum, A. H., Schlüper, H. M. M., Hausheer, F. H., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10434 · Cited by 43
Raymond, É., Campone, M., Stupp, R., Menten, J. J., Chollet, P. J. M., Lesimple, T., Féty, R., Lacombe, D., Paolettí, X., & Fumoleau, P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00070-9 · Cited by 43
Radiosensitization with chemotherapeutic agents
Caffo, O. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00382-8 · Cited by 41
Sadzuka, Y., Hirotsu, S., & Hirota, S. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00737.x · Cited by 35
Water Soluble Inhibitors of Topoisomerase I: Quaternary Salt Derivatives of Camptothecin
Lackey, K. E., Sternbach, D. D., Croom, D. K., Emerson, D. L., Evans, M. G., Leitner, P. L., Luzzio, M. J., McIntyre, G. D., Vuong, A., Yates, J., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950507y · Cited by 35
Chang, J.-Y., Guo, X., Chen, H., Jiang, Z., Fu, Q., Wang, H., Bastow, K. F., Zhu, X.-K., Guan, J., Lee, K., et al. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00363-9 · Cited by 28
Synthetic approaches to camptothecin
Shamma, M., & Novák, L. (1969) · Tetrahedron · doi:10.1016/s0040-4020(01)82777-0 · Cited by 27
A total synthesis of (±)-camptothecin
Shamma, M., SMITHERS, D. A., & Georoiev, V. S. (1973) · Tetrahedron · doi:10.1016/0040-4020(73)80129-2 · Cited by 17
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Multidimensional Drug Profiling By Automated Microscopy
Perlman, Z. E., Slack, M. D., Feng, Y., Mitchison, T. J., Wu, L. F., & Altschuler, S. J. (2004) · Science · doi:10.1126/science.1100709 · Cited by 660
Recent Advances in the Friedländer Reaction
Marco-Contelles, J., Pérez-Mayoral, E., Samadi, A., Carreiras, M. D. C., & Soriano, E. (2009) · Chemical Reviews · doi:10.1021/cr800482c · Cited by 666
Supramolecular Nanostructures Formed by Anticancer Drug Assembly
Cheetham, A. G., Zhang, P., Lin, Y.-A., Lock, L. L., & Cui, H. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3115983 · Cited by 517
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Metadata
- Authors
- Thomas, C. J., Rahier, N. J., & Hecht, S. M.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 12
- Issue
- 7
- Pages
- 1585-1604
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2070534090
- Cited by
- 451
- References
- 102
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.